Teva Pharmaceutical Industries Ltd (TEVA.TA)
14 Aug 2018
* Company still sees FDA approval of migraine drug mid-September
TEL AVIV, Aug 2 Israel's heavily indebted Teva Pharmaceutical Industries reported a smaller than-expected drop in second-quarter profit on Thursday and raised its profit outlook for the full year.
** April-June quarter should be weak for Cadila Healthcare Ltd and Lupin Ltd with sharp declines in U.S. sales q-o-q - Credit Suisse (CS)
JERUSALEM Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay.
JERUSALEM, May 23 Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as soon as mid-September, after an initial delay.
JERUSALEM, May 23 Israeli drugmaker Teva Pharmaceutical Industries said on Wednesday it could launch its migraine treatment as early as mid-September, after an initial delay.
May 15 Warren Buffett's Berkshire Hathaway Inc on Tuesday said it has more than doubled its investment in generic drugmaker Teva Pharmaceutical Industries Ltd , and confirmed it has become Apple Inc's second-largest shareholder.
* TEVA CANADA ANNOUNCES THE LAUNCH OF TEVA-CYCLOSPORINE® OPHTHALMIC EMULSION, THE FIRST GENERIC VERSION OF RESTASIS® IN CANADA FOR THE TREATMENT OF DRY EYE DISEASE
* Teva's North American generic product sales down 23 pct (Adds comments from CEO interview, conference call, analyst quote)
* RESTRUCTURING PLAN ON-TRACK TO ACHIEVE $1.5 BILLION OF SAVINGS IN 2018 AND $3.0 BILLION BY END OF 2019